Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07243704Phase 3Not Yet Recruiting

Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage

Role: collaborator

NCT02040714Enrolling By Invitation

Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

Role: collaborator

NCT03788213Not ApplicableRecruiting

One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer

Role: collaborator

NCT04351217Not ApplicableCompleted

Music vs Relaxation Training in Craving Reduction in Alcohol Dependence Syndrome

Role: lead

NCT03727243Unknown

Molecular Diagnosis and Risk Stratification of Sepsis in India

Role: collaborator

All 5 trials loaded